共 50 条
- [27] Clinical Benefit of Adalimumab Dose Adjustment for Patients With Moderately to Severely Active Crohn's Disease in EXTEND AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S474 - S474
- [28] Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 425 - 434
- [30] Meta-analysis of placebo remission rate for patients with moderately to severely active Crohn's disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S380 - S381